Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Osteoporosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01992159
What this trial is testing

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis (PMO)
Amgen 252
Not applicableLooking for participantsNCT06608862
What this trial is testing

The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults

Who this might be right for
OsteoporosisOsteopeniaFracture Reduction+8 more
Bundeswehr University Munich 150
Early research (Phase 1)Study completedNCT00464412
What this trial is testing

The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis

Who this might be right for
Osteoporosis
Valdosta State University 135
Testing effectiveness (Phase 2)Study completedNCT01144377
What this trial is testing

LY2541546 in Women With Low Bone Mineral Density

Who this might be right for
Osteoporosis
Eli Lilly and Company 154
Testing effectiveness (Phase 2)Study completedNCT00643331
What this trial is testing

The Effect of Exercise in Postmenopausal Women with Low Bone Density

Who this might be right for
OsteoporosisOsteopenia
University of Melbourne 38
Early research (Phase 1)Not Yet RecruitingNCT07741136
What this trial is testing

Pharmacokinetics of Zoledronic Acid in Patients on Dialysis

Who this might be right for
Chronic Kidney DiseaseOsteoporosisDialysis
University of Campinas, Brazil 24
Large-scale testing (Phase 3)Study completedNCT00046137
What this trial is testing

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company
Not applicableStudy completedNCT00655577
What this trial is testing

Exercise and Prevention of Hip Fractures

Who this might be right for
Bone Mineral DensityStrengthBalance+2 more
University of Oulu 160
Testing effectiveness (Phase 2)Study completedNCT00043186
What this trial is testing

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral Density
Amgen 412
Not applicableUnknownNCT04055805
What this trial is testing

Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population

Who this might be right for
Breast Cancer FemaleOsteoporosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 700
Not applicableStudy completedNCT03895333
What this trial is testing

Hearing Loss and Osteoporosis

Who this might be right for
Hearing LossOsteoporosis, Postmenopausal
Kanuni Sultan Suleyman Training and Research Hospital 160
Testing effectiveness (Phase 2)Ended earlyNCT00960934
What this trial is testing

A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 383
Early research (Phase 1)Study completedNCT01293487
What this trial is testing

Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.

Who this might be right for
OsteopeniaOsteoporosisBone Disease
Pfizer 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07806331
What this trial is testing

Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass

Who this might be right for
Postmenopausal OsteoporosisLow Bone Mass
Transcenta Therapeutics (Hangzhou) Co., Ltd. 110
Post-approval studies (Phase 4)Study completedNCT00887354
What this trial is testing

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Who this might be right for
Osteoporosis
Eli Lilly and Company 224
Post-approval studies (Phase 4)UnknownNCT02389179
What this trial is testing

Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics

Who this might be right for
Vitamin D Deficiency
Sharifah Faradila bt Wan Muhamad Hatta 150
Large-scale testing (Phase 3)Study completedNCT05352516
What this trial is testing

Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Who this might be right for
Postmenopausal
Shanghai Henlius Biotech 514
Testing effectiveness (Phase 2)Study completedNCT00918749
What this trial is testing

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis
Warner Chilcott 205
Not applicableStudy completedNCT02066480
What this trial is testing

Improved Screening for Osteoporosis

Who this might be right for
Osteoporosis
Centre Hospitalier Departemental Vendee 3,226
Post-approval studies (Phase 4)Study completedNCT00402441
What this trial is testing

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 260
Next Page